Capital Advisors Ltd’s ImageneBio Inc IMA Stock Holding History

Capital Advisors Ltd’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2	Closed	–	–	1351
2022 Q2	$0	Buy	+2	New	+$110	﹤0.01%	1148

Other funds holding IMA

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Advisors Ltd's IMA Position: Q3 2022 in Review

Capital Advisors Ltd sold out of ImageneBio Inc (IMA) in Q3 2022, closing a stake of 2 shares.

Capital Advisors Ltd first reported a position in IMA in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 42 funds tracked by Wall St. Rank hold IMA as of Q3 2022.

Capital Advisors Ltd reported no remaining ImageneBio Inc position as of Q3 2022 after selling out during the quarter.
Capital Advisors Ltd sold 2 ImageneBio Inc shares in Q3 2022.
Capital Advisors Ltd first reported a position in ImageneBio Inc in Q2 2022 and held it in 1 quarter.
Capital Advisors Ltd's ImageneBio Inc position peaked at $0 in Q2 2022.
42 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2022.

Based on Capital Advisors Ltd's 13F filing for Q3 2022, filed 9 Nov 2022.